Funding Rounds
Integra Therapeutics

Integra Therapeutics Series A (2024, $11M)

Integra Therapeutics

Creator of gene writing tools to boost the efficiency and safety of advanced therapies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $11.40M

Investors